NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, […]
CHENGDU, China, April 02, 2025 (GLOBE NEWSWIRE) — WF International Limited (the “Company”) (NASDAQ: WXM), an integrated electromechanical solutions company […]